Study of Selinexor Combined With Olaparib in Relapsed/Refractory Extensive Stage Small Cell Lung Cancer
Clinical trial NCT05975944 · UNKNOWN
Trial details
- NCT number
- NCT05975944
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2023-09-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.